DS
GSK icon

DRW Securities’s GSK GSK Stock Holding History

DRW Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-112,960
Closed -$5.01M – 302
2017
Q4 		$5.01M Buy
+112,960
New +$5.22M 0.53% 25
2017
Q3 		– Sell
-34,000
Closed -$1.83M – 72
2017
Q2 		$1.83M Buy
+34,000
New +$1.81M 0.32% 21

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DRW Securities's GSK Position: Q1 2026 in Review

DRW Securities increased its GSK (GSK) stake by 257% in Q1 2026, buying an estimated $8.28M and bringing the position to 212,287 shares worth $11.7M. The position accounts for 0.16% of the portfolio, ranked #62.

DRW Securities first reported a position in GSK in Q4 2014 and has held it in 11 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • DRW Securities held 212,287 shares of GSK worth $11.7M as of Q1 2026.
  • DRW Securities bought 152,749 GSK shares in Q1 2026, an estimated $8.28M.
  • GSK made up 0.16% of DRW Securities's portfolio in Q1 2026, its #62 holding.
  • DRW Securities first reported a position in GSK in Q4 2014 and has held it in 11 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.